73713-92-5 Usage
Uses
Used in the Rubber Industry:
2-Mercaptobenzoxazol-4-ol is used as a chemical additive to enhance the processing and mechanical properties of rubber products, especially in tire production. It serves as an antioxidant and antiozonant, safeguarding rubber from degradation due to exposure to oxygen and ozone.
Used in Pharmaceutical Synthesis:
In the pharmaceutical sector, 2-Mercaptobenzoxazol-4-ol is utilized as a key intermediate in the synthesis of various organic compounds and pharmaceuticals, contributing to the development of new drugs and therapeutic agents.
Safety Precautions:
It is crucial to handle 2-Mercaptobenzoxazol-4-ol with care, as it may pose risks if ingested, inhaled, or comes into contact with the skin, highlighting the importance of proper safety measures during its use and manipulation.
Check Digit Verification of cas no
The CAS Registry Mumber 73713-92-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,7,1 and 3 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 73713-92:
(7*7)+(6*3)+(5*7)+(4*1)+(3*3)+(2*9)+(1*2)=135
135 % 10 = 5
So 73713-92-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H5NO2S/c9-4-2-1-3-5-6(4)8-7(11)10-5/h1-3,9H,(H,8,11)
73713-92-5Relevant academic research and scientific papers
N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
-
, (2010/12/29)
The present invention relates to N-(hetero)aryl-pyrrolidine derivatives of Formula I: which are JAK inhibitors, such as selective JAK1 inhibitors, useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.
Design and synthesis of highly potent and selective human peroxisome proliferator-activated receptor α agonists
Yamazaki, Yukiyoshi,Abe, Kazutoyo,Toma, Tsutomu,Nishikawa, Masahiro,Ozawa, Hidefumi,Okuda, Ayumu,Araki, Takaaki,Oda, Soichi,Inoue, Keisuke,Shibuya, Kimiyuki,Staels, Bart,Fruchart, Jean-Charles
, p. 4689 - 4693 (2008/02/11)
A combination of benzoxazole, phenoxyalkyl side chain, and phenoxybutyric acids was identified as a highly potent and selective human peroxisome proliferator-activated receptor α (PPARα) agonist. The synthesis, structure-activity relationship (SAR) studies, and in vivo activities of the representative compounds are described.
